NCT06161272 2023-12-07Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPiGuangxi Medical UniversityPhase 2 Unknown80 enrolled
NCT04229615 2022-04-25A Study of Fluzoparib±Apatinib Versus Placebo Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on First-Line Platinum-Based ChemotherapyJiangsu HengRui Medicine Co., Ltd.Phase 3 Unknown690 enrolled